Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

Paller, Channing J; Barata, Pedro C; Lorentz, Justin; Appleman, Leonard J; Armstrong, Andrew J; DeMarco, Tiffani A; Dreicer, Robert; Elrod, Jo Ann B; Fleming, Mark; George, Christopher; Heath, Elisabeth I; Hussain, Maha H A; Mao, Shifeng; McKay, Rana R; Morgans, Alicia K; Orton, Matthew; Pili, Roberto; Riedel, Elyn; Saraiya, Biren; Sigmond, Joelle; Sokolova, Alexandra; Stadler, Walter M; Tran, Christina; Macario, Natalie; Vinson, Jacob; Green, Rebecca; Cheng, Heather H.

Prostate ; 84(3): 292-302, 2024 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-37964482

2.

Optimizing the doses of cancer drugs after usual dose finding.

Strohbehn, Garth W; Stadler, Walter M; Boonstra, Philip S; Ratain, Mark J.

Clin Trials ; 21(3): 340-349, 2024 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-38148731

3.

Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial.

Heiss, Brian L; Geynisman, Daniel M; Martinez, Elia; Wong, Alvin S C; Yong, Wei Peng; Szmulewitz, Russell Z; Stadler, Walter M.

Support Care Cancer ; 30(3): 2803-2810, 2022 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-34845502

4.

Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer.

Lee, Richard T; Kwon, Nancy; Wu, Jimin; To, Connie; To, Steven; Szmulewitz, Russell; Tchekmedyian, Raffi; Holmes, Holly M; Olopade, Olufunmilayo I; Stadler, Walter M; Von Roenn, Jamie.

Cancer ; 127(11): 1827-1835, 2021 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-33524183

5.

Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).

Harrison, Michael R; Costello, Brian A; Bhavsar, Nrupen A; Vaishampayan, Ulka; Pal, Sumanta K; Zakharia, Yousef; Jim, Heather S L; Fishman, Mayer N; Molina, Ana M; Kyriakopoulos, Christos E; Tsao, Che-Kai; Appleman, Leonard J; Gartrell, Benjamin A; Hussain, Arif; Stadler, Walter M; Agarwal, Neeraj; Pachynski, Russell K; Hutson, Thomas E; Hammers, Hans J; Ryan, Christopher W; Inman, Brant A; Mardekian, Jack; Borham, Azah; George, Daniel J.

Cancer ; 127(13): 2204-2212, 2021 07 01.

Artículo en Inglés | MEDLINE | ID: mdl-33765337

6.

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.

Seiwert, Tanguy Y; Kochanny, Sara; Wood, Kevin; Worden, Francis P; Adkins, Douglas; Wade, James L; Sleckman, Bethany G; Anderson, Daniel; Brisson, Ryan J; Karrison, Theodore; Stadler, Walter M; Vokes, Everett E.

Cancer ; 126(14): 3237-3243, 2020 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-32365226

7.

A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Kochanny, Sara E; Worden, Francis P; Adkins, Douglas R; Lim, Dean W; Bauman, Julie E; Wagner, Stephanie A; Brisson, Ryan J; Karrison, Theodore G; Stadler, Walter M; Vokes, Everett E; Seiwert, Tanguy Y.

Cancer ; 126(10): 2146-2152, 2020 05 15.

Artículo en Inglés | MEDLINE | ID: mdl-32073648

8.

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.

Rini, Brian I; Powles, Thomas; Atkins, Michael B; Escudier, Bernard; McDermott, David F; Suarez, Cristina; Bracarda, Sergio; Stadler, Walter M; Donskov, Frede; Lee, Jae Lyun; Hawkins, Robert; Ravaud, Alain; Alekseev, Boris; Staehler, Michael; Uemura, Motohide; De Giorgi, Ugo; Mellado, Begoña; Porta, Camillo; Melichar, Bohuslav; Gurney, Howard; Bedke, Jens; Choueiri, Toni K; Parnis, Francis; Khaznadar, Tarik; Thobhani, Alpa; Li, Shi; Piault-Louis, Elisabeth; Frantz, Gretchen; Huseni, Mahrukh; Schiff, Christina; Green, Marjorie C; Motzer, Robert J.

Lancet ; 393(10189): 2404-2415, 2019 06 15.

Artículo en Inglés | MEDLINE | ID: mdl-31079938

9.

Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.

Godfrey, James K; Nabhan, Chadi; Karrison, Theodore; Kline, Justin P; Cohen, Kenneth S; Bishop, Michael R; Stadler, Walter M; Karmali, Reem; Venugopal, Parameswaran; Rapoport, Aaron P; Smith, Sonali M.

Cancer ; 125(11): 1830-1836, 2019 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-30707764

10.

Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.

Borden, Brittany A; Galecki, Paige; Wellmann, Rebecca; Danahey, Keith; Lee, Sang Mee; Patrick-Miller, Linda; Sorrentino, Matthew J; Nanda, Rita; Koyner, Jay L; Polonsky, Tamar S; Stadler, Walter M; Mulcahy, Cathleen; Kavitt, Robert T; Ratain, Mark J; Meltzer, David O; O'Donnell, Peter H.

Pharmacogenet Genomics ; 29(2): 31-38, 2019 02.

Artículo en Inglés | MEDLINE | ID: mdl-30531377

11.

Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.

Borden, Brittany A; Lee, Sang Mee; Danahey, Keith; Galecki, Paige; Patrick-Miller, Linda; Siegler, Mark; Sorrentino, Matthew J; Sacro, Yasmin; Davis, Andrew M; Rubin, David T; Lipstreuer, Kristen; Polonsky, Tamar S; Nanda, Rita; Harper, William R; Koyner, Jay L; Burnet, Deborah L; Stadler, Walter M; Kavitt, Robert T; Meltzer, David O; Ratain, Mark J; O'Donnell, Peter H.

Pharmacogenomics J ; 19(6): 528-537, 2019 12.

Artículo en Inglés | MEDLINE | ID: mdl-30713337

12.

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Patel, Hiten D; Puligandla, Maneka; Shuch, Brian M; Leibovich, Bradley C; Kapoor, Anil; Master, Viraj A; Drake, Charles G; Heng, Daniel Yc; Lara, Primo N; Choueiri, Toni K; Maskens, Deborah; Singer, Eric A; Eggener, Scott E; Svatek, Robert S; Stadler, Walter M; Cole, Suzanne; Signoretti, Sabina; Gupta, Rajan T; Michaelson, Marc Dror; McDermott, David F; Cella, David; Wagner, Lynne I; Haas, Naomi B; Carducci, Michael A; Harshman, Lauren C; Allaf, Mohamad E.

Future Oncol ; 15(15): 1683-1695, 2019 May.

Artículo en Inglés | MEDLINE | ID: mdl-30968729

13.

Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.

Danzig, Matthew R; Mallin, Katherine; McKiernan, James M; Stadler, Walter M; Sridhar, Srikala S; Morgan, Todd M; Bochner, Bernard H; Lee, Cheryl T.

Cancer ; 124(12): 2507-2514, 2018 06 15.

Artículo en Inglés | MEDLINE | ID: mdl-29624636

14.

Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.

Wellmann, Rebecca; Borden, Brittany A; Danahey, Keith; Nanda, Rita; Polite, Blase N; Stadler, Walter M; Ratain, Mark J; O'Donnell, Peter H.

Cancer ; 124(14): 3052-3065, 2018 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-29742281

15.

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).

Monk, Paul; Liu, Glenn; Stadler, Walter M; Geyer, Susan; Huang, Ying; Wright, John; Villalona-Calero, Miguel; Wade, James; Szmulewitz, Russell; Gupta, Shilpa; Mortazavi, Amir; Dreicer, Robert; Pili, Roberto; Dawson, Nancy; George, Saby; Garcia, Jorge A.

Invest New Drugs ; 36(5): 919-926, 2018 10.

Artículo en Inglés | MEDLINE | ID: mdl-30083962

16.

Knowledge and distress in complex cancer care.

Stadler, Walter M; Hlubocky, Fay J; Hathaway, Feighanne.

Cancer ; 128(7): 1359-1360, 2022 04 01.

Artículo en Inglés | MEDLINE | ID: mdl-34890042

17.

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.

Dorff, Tanya B; Longmate, Jeff A; Pal, Sumanta K; Stadler, Walter M; Fishman, Mayer N; Vaishampayan, Ulka N; Rao, Amol; Pinksi, Jacek K; Hu, James S; Quinn, David I; Lara, Primo N.

Cancer ; 123(23): 4566-4573, 2017 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-28832978

18.

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.

Armstrong, Andrew J; Halabi, Susan; Eisen, Tim; Broderick, Samuel; Stadler, Walter M; Jones, Robert J; Garcia, Jorge A; Vaishampayan, Ulka N; Picus, Joel; Hawkins, Robert E; Hainsworth, John D; Kollmannsberger, Christian K; Logan, Theodore F; Puzanov, Igor; Pickering, Lisa M; Ryan, Christopher W; Protheroe, Andrew; Lusk, Christine M; Oberg, Sadie; George, Daniel J.

Lancet Oncol ; 17(3): 378-388, 2016 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-26794930

19.

Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.

Posadas, Edwin M; Ahmed, Rafi S; Karrison, Theodore; Szmulewitz, Russell Z; O'Donnell, Peter H; Wade, James L; Shen, James; Gururajan, Murali; Sievert, Margarit; Stadler, Walter M.

Prostate ; 76(3): 286-93, 2016 Feb 15.

Artículo en Inglés | MEDLINE | ID: mdl-26493492

20.

No interest, no conflict.

Stadler, Walter M.

Cancer ; 126(16): 3627-3628, 2020 08 15.

Artículo en Inglés | MEDLINE | ID: mdl-32497250

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: